BRANCATO, VIRGINIA
 Distribuzione geografica
Continente #
NA - Nord America 3.011
AS - Asia 2.486
EU - Europa 1.782
SA - Sud America 384
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 66
OC - Oceania 13
Totale 7.890
Nazione #
US - Stati Uniti d'America 2.840
IT - Italia 841
SG - Singapore 821
CN - Cina 573
HK - Hong Kong 318
BR - Brasile 281
VN - Vietnam 277
RU - Federazione Russa 238
FR - Francia 157
IE - Irlanda 107
CA - Canada 86
KR - Corea 84
DE - Germania 83
GB - Regno Unito 83
IN - India 74
BD - Bangladesh 73
FI - Finlandia 57
ID - Indonesia 44
NL - Olanda 40
AR - Argentina 39
TR - Turchia 39
JP - Giappone 36
SE - Svezia 31
ZA - Sudafrica 30
MX - Messico 28
PL - Polonia 25
CO - Colombia 23
IQ - Iraq 23
CH - Svizzera 17
ES - Italia 17
PH - Filippine 17
PT - Portogallo 16
PK - Pakistan 15
SA - Arabia Saudita 15
AT - Austria 14
CZ - Repubblica Ceca 13
CL - Cile 12
UZ - Uzbekistan 12
TW - Taiwan 11
AU - Australia 9
JO - Giordania 9
MA - Marocco 9
EC - Ecuador 8
HN - Honduras 8
JM - Giamaica 7
MY - Malesia 7
NI - Nicaragua 7
SV - El Salvador 7
UA - Ucraina 7
GT - Guatemala 6
IR - Iran 6
KE - Kenya 6
PY - Paraguay 6
CR - Costa Rica 5
DK - Danimarca 5
NP - Nepal 5
VE - Venezuela 5
BB - Barbados 4
BO - Bolivia 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RO - Romania 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BE - Belgio 3
CW - ???statistics.table.value.countryCode.CW??? 3
GP - Guadalupe 3
HR - Croazia 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
GD - Grenada 2
IL - Israele 2
KZ - Kazakistan 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
DM - Dominica 1
GE - Georgia 1
GF - Guiana Francese 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 7.737
Città #
Singapore 473
San Jose 389
Ashburn 382
Milan 307
Hong Kong 292
Council Bluffs 186
Hefei 150
Dublin 102
Ho Chi Minh City 102
Beijing 91
New York 86
Dallas 79
Seoul 78
Santa Clara 76
Chicago 75
Los Angeles 74
Hanoi 61
The Dalles 59
Rome 54
Buffalo 48
Helsinki 41
Lauterbourg 41
Columbus 38
Jakarta 33
Phoenix 33
São Paulo 33
Atlanta 29
Montreal 23
Moscow 23
Tokyo 23
Turin 22
Johannesburg 20
Naples 19
Shanghai 19
Frankfurt am Main 18
Houston 18
Warsaw 18
Brooklyn 16
Biloxi 15
Boardman 15
Chennai 15
Denver 15
Groningen 15
Guangzhou 15
London 15
Orem 15
Bologna 14
Nuremberg 14
Washington 14
Baghdad 13
Brescia 13
Da Nang 13
North Bergen 13
Tukwila 13
Florence 12
Munich 12
Braga 11
Hyderabad 11
Monza 11
Toronto 11
Boston 10
Dhaka 10
Salt Lake City 10
Zurich 10
Amman 9
Amsterdam 9
Figino 9
Istanbul 9
Tashkent 9
Ankara 8
Rio de Janeiro 8
Seattle 8
Buenos Aires 7
Detroit 7
Managua 7
Manchester 7
Miami 7
Pittsburgh 7
Riyadh 7
San Francisco 7
San Salvador 7
Birmingham 6
Biên Hòa 6
Brno 6
Busto Arsizio 6
Bắc Ninh 6
Cagliari 6
Charlotte 6
Chengdu 6
Falkenstein 6
Ha Long 6
Kingston 6
Lahore 6
Mexico City 6
Philadelphia 6
Poplar 6
Richmond 6
Vienna 6
Berlin 5
Brasília 5
Totale 4.210
Nome #
Chitosan-Based Biomaterials: Insights into Chemistry, Properties, Devices, and Their Biomedical Applications 443
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 331
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 312
Mechanical Property of Hydrogels and the Presence of Adipose Stem Cells in Tumor Stroma Affect Spheroid Formation in the 3D Osteosarcoma Model 306
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 295
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 268
3D Bioprinting for Cancer Models 263
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 256
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 255
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 223
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 212
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 202
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 200
Tumor-Associated Protrusion Fluctuations as a Signature of Cancer Invasiveness 198
Synergistic Effect of Co-Culturing Breast Cancer Cells and Fibroblasts in the Formation of Tumoroid Clusters and Design of In Vitro 3D Models for the Testing of Anticancer Agents 181
Silk fibroin promotes mineralization of gellan gum hydrogels 180
Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model 178
Could 3D models of cancer enhance drug screening? 178
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 177
Convection patterns gradients of non-living and living micro-entities in hydrogels 173
3D cancer spheroids and microtissues 158
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 153
Tumor-stroma interactions alter the sensitivity of drug in breast cancer 149
Coupling Micro-Physiological Systems and Biosensors for Improving Cancer Biomarkers Detection 147
adipoSIGHT in Therapeutic Response: Consequences in Osteosarcoma Treatment 145
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer 144
Design of inhibitors of influenza virus membrane fusion: Synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series 143
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 143
An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression 143
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 142
3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues 139
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 137
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 135
Bioengineered Tumoral Microtissue: An In Vitro 3D Platform To Investigate Cell-ECM Interaction And Cancer Development 128
3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems 127
Decellularized matrices for tumor cell modeling 126
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 125
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 118
Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin 118
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 112
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 111
3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro 111
A straightforward method to produce decellularized dermis-based matrices for tumour cell cultures 105
Totale 7.890
Categoria #
all - tutte 27.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023249 0 0 0 0 45 72 47 29 6 18 19 13
2023/2024458 12 7 24 53 47 71 76 23 62 6 16 61
2024/20251.402 63 149 82 78 116 78 122 60 96 191 132 235
2025/20264.334 361 298 450 479 483 281 510 150 384 367 174 397
2026/20271.447 219 221 391 577 39 0 0 0 0 0 0 0
Totale 7.890